Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

You are here: Industry Insights > Market News > Pharmexcil’s 13th annual meet held in Hyderabad

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

FENOFIBRATE

2,2-diphenyl-(2R)-2-pyrrolidinemethanol

2,2-diphenyl-(2R)-2-pyrrolidinemethanol

5-Butyl-1H-Benzotriazole

5-Butyl-1H-Benzotriazole

3,3',4,4'-Biphenyltetracarboxylic dianhydride

3,3',4,4'-Biphenyltetracarboxylic dianhydride

Bilastine

ASPARTAME

Pharmexcil’s 13th annual meet held in Hyderabad

expressbpdOctober 13, 2017

Tag: Pharmexcil , Hyderabad , 13th

Favorites

Honours pharma companies with Outstanding Export Performance Award

Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently organised the 9th Edition of Outstanding Export Performance Award in Hyderabad.

The following companies received the awards:

Previous:‘OneUp’ trek challenge held for diabetes patients

Next:AbbVie obtains licence for Turnstone Biologics’ oncolytic viral immunotherapies

Related News

InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore

PharmaSourcesSeptember 08, 2025

InnoCare Pharma announced today that HIBRUKA (orelabrutinib) has been approved by the Health Sciences Authority of Singapore for the treatment of adult patients with relapsed or refractory marginal zone lymphoma .

From Molecule to Market: Innovations Accelerating the Future of Drug Development

Annie RoysSeptember 04, 2025

Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth

PRNewswireAugust 21, 2025

Pharmexcil’s 13th annual meet held in Hyderabad | Pharmasources.com

Sisram Medical Reports First-Half 2025 Results: Injectables Surge as AI-Powered EBD Strengthens Segment Positioning

PRNewswireAugust 20, 2025

Sisram Medical Ltd announced its unaudited consolidated interim results for the six months ended June 30, 2025 (the "Reporting Period").

You may like
More>>

PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM

LINCOMYCIN HCL

GENTAMYCIN SULPHATE macrolides

GENTAMYCIN SULPHATE macrolides

CEFALEXINE cephalosporins

CEFALEXINE cephalosporins

CEFRADINE cephalosporins

CEFRADINE cephalosporins

CEFADROXIL cephalosporins

CEFADROXIL cephalosporins

CEFIXIME cephalosporins

CEFIXIME cephalosporins

CEFATHIAMIDINE cephalosporins

CEFATHIAMIDINE cephalosporins

CEFMINOX SODIUM cephalosporins

CEFMINOX SODIUM cephalosporins

CEFOXITIN SODIUM cephalosporins

CEFOXITIN SODIUM cephalosporins

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2025 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 滬ICP備05034851號-182 滬公網安備31010402010101號
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight July 2025

PharmaSources Customer Service